|
| Press Releases |
|
 |
|
| Thursday, April 23, 2026 |
|
|
NEC Announces Strategic Collaboration with Anthropic Focused on Enterprise AI |
| NEC Corporation (TSE: 6701) today announced a strategic collaboration with Anthropic PBC (Anthropic) to accelerate the utilization of AI in the Japanese enterprise sector. more info >> |
|
| Wednesday, April 22, 2026 |
|
|
NEC Receives Company of the Year recognition in Global Biometric Solutions from Frost & Sullivan |
| NEC Corporation (NEC; TSE: 6701) becomes the first company in the biometrics industry to receive Frost & Sullivan's Global Biometric Solutions Company of the Year recognition(1), underscoring its leadership and innovation. more info >> |
|
| Sunday, April 19, 2026 |
|
|
NEC to Supply Nine Types of Defense Equipment for Tthree Australian Frigates |
| NEC Corporation (TSE: 6701) has signed a contract with the Commonwealth of Australia to supply nine types of defense equipment that will be installed on all three ships in the initial phase of the Royal Australian Navy's SEA3000 frigate procurement program, which involves the procurement of a total of 11 ships. more info >> |
|
| Friday, April 10, 2026 |
|
|
IFS and NEC to Deploy Next-Generation Core System IFS Cloud for Hoshizaki |
| IFS AB (IFS), the leading provider of Industrial AI software, and NEC Corporation (NEC; TSE: 6701) have announced that Hoshizaki Corporation, a world-leading manufacturer of commercial foodservice equipment, will implement IFS Cloud as its next-generation core system to transform its legacy ERP systems. more info >> |
|
| Thursday, April 9, 2026 |
|
|
NEC's Automated Negotiation AI recognized as a Use Case in Gartner(R) Research |
| NEC Corporation's automated negotiation AI initiative has been named as a use case in "Deploy AI Agents in Procurement: A Roadmap to Success" (*1), a research report published by Gartner. more info >> |
|
| Friday, April 3, 2026 |
|
|
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer |
| Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Bio B.V., a wholly owned subsidiary of NEC Corporation, a leader in IT, network and AI technologies, announce the signing of a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer. more info >> |
|
| Tuesday, March 31, 2026 |
|
|
NEC Supports Ooredoo Algeria in Modernizing Enterprise Network Security with high-performance next-generation firewalls (NGFW) |
| NEC Corporation (NEC; TSE: 6701), a leading global IT and network transformation services provider, today announced the deployment of high-performance next-generation firewalls for Ooredoo Algeria, one of Algeria's largest mobile operators. more info >> |
|
| Thursday, March 26, 2026 |
|
|
Royal Healthcare in Singapore provides NEC's "FonesVisuas Test" for Disease Risk Prediction |
| NEC Corporation (NEC; TSE: 6701) announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare (*1), a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality. more info >> |
|
| Wednesday, March 25, 2026 |
|
|
Sumitomo Heavy Industries and NEC to develop system capable of identifying and reporting near-miss incidents |
| Sumitomo Heavy Industries, Ltd. (SHI) and NEC Corporation (NEC) will begin joint development in April 2026 of a system that automatically identifies near-miss incidents at construction sites and generates reports as part of promoting safety. more info >> |
|
|
NEC Orchestrating Future Fund Invests in U.S.-based AGI7, Provider of "Alpha Vision" Platform for Autonomous Operations of AI Agents in Physical Spaces |
| NEC Corporation's (NEC; TSE: 6701) ecosystem-based corporate venture capital (CVC) fund, NEC Orchestrating Future Fund (NOFF), has invested in new windowAGI7, Inc. (AGI7), provider of the Physical AI platform "Alpha Vision." more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
Apr 28, 2026 1:00 JST
|
|
|
Buffalo Potash Announces Preliminary Economic Assessment for Disley Project with After-Tax NPV of US$1.1B and IRR of 30%; Releases Results from Maiden 43-101 Mineral Resource Estimate
Apr 27, 2026 21:00 HKT/SGT
|
|
|
Standard Chartered GBA Business Confidence Indices highlight resilience of GBA corporates despite Middle East uncertainties
Apr 27, 2026 20:51: JST
|
|
|
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)
Apr 27, 2026 20:00: JST
|
|
|
Standard Chartered GBA Business Confidence Indices highlight resilience of GBA corporates despite Middle East uncertainties
Apr 27, 2026 19:51 HKT/SGT
|
|
|
貿發局七大時尚創意及授權盛事 今日盛大揭幕
Apr 27, 2026 19:45 HKT/SGT
|
|
|
HKTDC's seven flagship lifestyle and licensing events open today
Apr 27, 2026 19:37: JST
|
|
|
康哲藥業就已上市原研藥靜脈鐵劑莫諾菲和科莫非簽訂獨家商業化與供應協議
Apr 27, 2026 19:35 HKT/SGT
|
|
|
康哲药业就已上市原研药静脉铁剂莫诺菲和科莫非签订独家商业化与供应协议
Apr 27, 2026 19:24 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)
Apr 27, 2026 19:00 HKT/SGT
|
|
|
Kincora Investor Webinar Invitation
Apr 27, 2026 18:59 HKT/SGT
|
|
|
HKTDC's seven flagship lifestyle and licensing events open today
Apr 27, 2026 18:37 HKT/SGT
|
|
|
Honda、2026年3月度 四輪車 生産・販売・輸出実績を発表
Apr 27, 2026 15:10: JST
|
|
|
トヨタ、2025年度 販売・生産・輸出実績を発表
Apr 27, 2026 13:35: JST
|
|
|
CTF Life Launches MyWealth Beyond Savings Insurance Plan
Apr 27, 2026 13:43 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
